Essential Thrombocythemia

Essential thrombocythemia (ET) is a rare, chronic blood disorder where your bone marrow makes too many platelets. These extra platelets can lead to serious complications like blood clots or bleeding. While there is no cure, treatments help manage symptoms and reduce the risk of complications, allowing most people to live a normal lifespan.

What is Essential Thrombocythemia?

Essential thrombocythemia (ET) is a rare, chronic blood disorder where your bone marrow produces too many platelets (thrombocytes). Platelets are tiny blood cells that help your blood clot. In ET, the excess platelets can make your blood too thick, leading to problems like blood clots or unusual bleeding.

Your bone marrow is the soft, spongy tissue inside your bones that makes all your blood cells, including red blood cells, white blood cells, and platelets. Normally, your body produces just the right number of platelets needed to stop bleeding when you get a cut or injury. In essential thrombocythemia, the bone marrow goes into overdrive, producing far too many platelets. This condition is considered a type of myeloproliferative neoplasm, which means it's a chronic (long-lasting) blood cancer involving the uncontrolled growth of blood cells. The main concerns with ET are the potential for serious complications. The high number of platelets can either make your blood too sticky, leading to dangerous blood clots (thrombosis), or paradoxically, it can interfere with normal clotting, causing unusual bleeding. These complications can affect various parts of your body, including your brain, heart, and lungs.

Symptoms

Many people with essential thrombocythemia (ET) have no symptoms, and the condition is often found during routine blood tests. When symptoms do occur, they are usually related to blood clots or bleeding, and can include headaches, dizziness, vision changes, or a burning sensation in the hands and feet.

If symptoms appear, they often develop slowly over time. Common symptoms related to blood clots include headaches, dizziness, weakness, and temporary changes in vision. You might also experience numbness or tingling in your hands and feet, or a burning, throbbing, and redness in your hands and feet, a condition called erythromelalgia. Less commonly, symptoms can include mild chest pain or lightheadedness. These symptoms occur because the excess platelets can block small blood vessels, reducing blood flow to certain areas of your body. For example, a temporary blockage in a brain blood vessel can cause a transient ischemic attack (TIA), leading to temporary vision changes or weakness. Despite the risk of clotting, some people with ET may experience unusual bleeding. This can manifest as easy bruising, nosebleeds, bleeding gums, or even gastrointestinal bleeding. This happens because the very high number of platelets can sometimes interfere with the normal clotting process, preventing them from working effectively.

Causes & risk factors

The exact cause of essential thrombocythemia (ET) is unknown, but it is a disorder of the bone marrow, the spongy tissue inside your bones that makes blood cells. Most cases are linked to specific gene mutations, such as JAK2, CALR, or MPL, which cause the bone marrow to produce too many platelets.

Essential thrombocythemia is not caused by lifestyle factors or environmental exposures. Instead, it originates from a problem within the bone marrow itself. Researchers have found that a significant majority of people with ET have acquired (not inherited) mutations in certain genes. The most common gene mutation found in ET is called JAK2. Other gene mutations, such as CALR (calreticulin) or MPL, are also frequently identified. These mutations change the way bone marrow cells grow and divide, leading to the overproduction of platelets. It is important to understand that these gene mutations are typically acquired during a person's lifetime and are not usually passed down from parents to children. This means that ET is generally not an inherited condition. The reason why these specific gene mutations occur in the first place is not yet fully understood.

How it's diagnosed

Essential thrombocythemia (ET) is often diagnosed after a routine blood test shows a very high platelet count. To confirm the diagnosis, your doctor will perform additional tests, including a complete blood count, a bone marrow biopsy, and genetic tests to look for specific gene mutations.

The diagnostic process usually begins when a routine complete blood count (CBC) reveals an abnormally high number of platelets. If your doctor suspects ET, they will conduct a thorough physical exam and review your medical history to rule out other causes of high platelet counts, known as secondary thrombocytosis. To confirm ET, a bone marrow biopsy and aspiration are typically performed. During this procedure, a small sample of bone marrow is taken from your hip bone. This sample is then examined under a microscope to look for specific changes in the bone marrow cells that are characteristic of ET and to rule out other blood disorders. Genetic testing is also a crucial part of the diagnosis. Blood or bone marrow samples are tested for the presence of gene mutations, particularly JAK2, CALR, or MPL. Finding one of these mutations helps confirm the diagnosis of ET and distinguishes it from other conditions that might cause similar symptoms or high platelet counts.

Treatment options

Treatment for essential thrombocythemia (ET) aims to reduce symptoms and prevent serious complications like blood clots or bleeding, as there is no cure. Common treatments include low-dose aspirin to prevent clots and medications like hydroxyurea, anagrelide, or interferon alfa to lower your platelet count.

Since there is currently no cure for essential thrombocythemia, treatment focuses on managing the condition and preventing complications. Your treatment plan will depend on your age, overall health, and your risk of developing blood clots or bleeding. For many people, especially those at lower risk of complications, low-dose aspirin is a primary treatment. Aspirin helps to thin the blood and reduce the stickiness of platelets, thereby lowering the risk of blood clots. It is important to take aspirin only as directed by your doctor, as it can also increase the risk of bleeding. If you are at a higher risk of complications or if aspirin alone is not enough, your doctor may prescribe medications to lower your platelet count. These include hydroxyurea, which reduces the production of blood cells in the bone marrow; anagrelide, which specifically targets and lowers platelet counts; and interferon alfa, another medication that slows down bone marrow production. Your doctor will discuss the best option for you, considering potential side effects and your individual health needs.

Recovery & outlook

Essential thrombocythemia (ET) is a chronic condition that requires ongoing management, but most people with ET can live a normal lifespan with proper treatment. Regular monitoring and adherence to your treatment plan are crucial to manage symptoms and reduce the risk of complications such as blood clots, bleeding, or, rarely, progression to other blood disorders.

ET is a lifelong condition, meaning it cannot be cured. However, with consistent medical care and adherence to your treatment plan, the outlook for most people with ET is generally good. Many individuals can live a normal or near-normal lifespan, managing their symptoms and preventing serious complications. Ongoing monitoring by your healthcare team is essential. This typically involves regular blood tests to check your platelet count and overall blood health, as well as monitoring for any new symptoms or changes in your condition. Your doctor will adjust your treatment as needed to keep your platelet count within a safe range and minimize risks. While most people manage ET well, there are potential complications. These can include serious blood clots leading to a stroke, heart attack, deep vein thrombosis (DVT), or pulmonary embolism (PE). In rare cases, ET can progress to other more serious blood disorders, such as myelofibrosis or acute myeloid leukemia (AML). Discussing these possibilities with your doctor can help you understand your individual risk and what to watch for.

When to see a doctor

You should see your doctor if you experience any new or worsening symptoms of essential thrombocythemia (ET), especially signs of a blood clot or unusual bleeding. Seek immediate medical attention for symptoms like sudden chest pain, severe headache, weakness on one side of your body, trouble speaking, or significant unexplained bleeding.

It is crucial to be aware of symptoms that require prompt medical attention. If you experience any signs of a blood clot, such as sudden chest pain, shortness of breath, pain or swelling in a leg, or sudden weakness or numbness on one side of your body, seek emergency care immediately. Other urgent symptoms include a severe headache, sudden vision changes, or trouble speaking, which could indicate a stroke or transient ischemic attack (TIA). Similarly, any signs of significant or uncontrolled bleeding warrant immediate medical evaluation. This includes unusually heavy nosebleeds, bleeding from your gums that won't stop, blood in your urine or stool (which may appear black and tarry), or extensive bruising without a clear cause. Always communicate any new or concerning symptoms to your healthcare provider. Even if they don't seem severe, it's important for your doctor to assess them and ensure your treatment plan is effective in preventing complications. Never hesitate to seek medical advice for any changes in your health.

Frequently asked questions

Is essential thrombocythemia a type of cancer?

Yes, essential thrombocythemia is considered a type of chronic blood cancer, specifically a myeloproliferative neoplasm. This means it involves the uncontrolled growth of blood cells, in this case, platelets, in the bone marrow.

Can essential thrombocythemia be cured?

No, essential thrombocythemia is a chronic condition that currently has no cure. However, treatments are very effective at managing symptoms and preventing serious complications, allowing most people to live a normal lifespan with proper care.

What is the life expectancy for someone with essential thrombocythemia?

With proper management and consistent treatment, most people with essential thrombocythemia have a normal or near-normal life expectancy. Regular monitoring by a healthcare professional and adherence to your treatment plan are key to a good outlook.

Are there any dietary restrictions for essential thrombocythemia?

There are no specific dietary restrictions directly for essential thrombocythemia itself. However, your doctor may recommend a heart-healthy diet to reduce your overall risk of cardiovascular complications, especially if you are at high risk for blood clots.

Can essential thrombocythemia affect pregnancy?

Yes, essential thrombocythemia can pose risks during pregnancy for both the mother and the baby, including an increased risk of blood clots, bleeding, or miscarriage. Close monitoring and specialized management by a hematologist and obstetrician are essential for a safe pregnancy.

What is the difference between essential thrombocythemia and secondary thrombocytosis?

Essential thrombocythemia is a primary bone marrow disorder where the body makes too many platelets without a clear external cause, often due to gene mutations. Secondary thrombocytosis (also called reactive thrombocytosis) is when a high platelet count is caused by another underlying condition, such as infection, inflammation, iron deficiency, or recent surgery.

Sources

• MedlinePlus — Essential Thrombocythemia
• Mayo Clinic — Essential Thrombocythemia
• Cochrane Library — Essential Thrombocythemia